Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients
about
Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation.Human immunodeficiency virus causes mononuclear phagocyte dysfunctionClinical applications of recombinant human colony-stimulating factors.The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.Haematopoietic growth factors in children with neutropenia.Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alphaHemopoietic growth factors: a review.Specific human granulocyte-macrophage colony-stimulating factor antagonists.Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.Antiviral therapy: current concepts and practicesThe immunocompromised host: HIV infection.G-CSF and GM-CSF in clinical trialsThe use of hematopoietic growth factors in HIV infection and AIDS-related malignancies.Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cellsConformation of four peptides corresponding to the alpha-helical segments of human GM-CSF.Anticandidal activity and interleukin-1 beta and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS.Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.Immunoglobulin A: A next generation of therapeutic antibodies?Abnormalities in host defense associated with HIV infection.Haematological manifestations of human immune deficiency virus infection.Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines.Integrating worldwide marketing needs and clinical research.Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding.Clinical significance of the haemopoietic growth factors.Clinical significance of neutrophil functional activity in HIV infection.In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes.The effects of human immunodeficiency virus infection on macrophage phagocytosis of Candida.Identification of an antigenic domain near the C terminus of human granulocyte-macrophage colony-stimulating factor and its spatial localization.
P2860
Q33372274-67B0180C-A3C1-4A19-BCA3-003A0BD0F726Q33593072-65E39F2F-44B8-4D8E-9662-69C2D6FCFF86Q34102759-87BC7290-B7AB-4A79-A981-E8CEE48F233DQ34218284-D1C7B160-89C5-4BE2-B0DA-E89CBD877B72Q34527650-174B7E44-777C-4E6D-AA9D-9CDD77116E13Q35088444-9B90F70C-1D93-436E-B379-ABE713E999A9Q35328369-10BD9D90-4E36-4060-BAD7-40258C141BD6Q35536111-86BC7F5E-5D32-4D18-A10E-F532A6F00DE6Q35810392-046042FD-AE5B-4D06-9ABB-C2FE73411306Q36070394-21E9381A-BB2B-4CBA-BBC6-2C768BEAF50DQ36328685-AD14DDE7-6A10-4AEA-8C97-1FF9B8AE0687Q36631539-354D22A4-6070-4A98-BCF1-E93B94D45F0EQ36669963-8BA30B1F-6C6C-45C7-92B1-4DCAB134C667Q36759593-91AAD793-9421-4A33-BDB1-5066BE3D7833Q36894422-363DC06E-FC75-4274-83CE-B7085B8626FFQ37068747-557A59CA-7E0D-4D33-81E0-307ADEAAD268Q37810266-26EB69E9-E948-4B70-AD1E-2E2BCBABD8E5Q37892323-EA7D541B-32AF-4072-90BC-75175CFC3AEEQ38108962-534B4D6A-0A93-46F6-A7B9-C9C9315289E2Q38603109-25F23C6A-1873-44E4-A075-D1DBC0197B54Q40672489-8D7F25C5-3F81-4E3C-AD0A-CA11311789A2Q40774779-590191A8-FA3D-4269-8197-B66D618BD7D2Q41518384-EAF641B7-03C3-4AD6-945E-0AA263F6BEB8Q43050834-46283F45-7FF6-4EE8-82AA-51081E1AB46DQ43728878-332668B3-D313-4EA9-859E-9296C0C4799AQ44884104-C87BC8E3-8E93-4C5D-A51C-47A609B6AD85Q45790664-C3E2DACA-5DBD-46A4-A4B6-B0B1A402900CQ47332912-787E0A09-96BB-4464-AA15-7938F9A862FD
P2860
Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Granulocyte-macrophage colony- ...... nodeficiency syndrome patients
@ast
Granulocyte-macrophage colony- ...... nodeficiency syndrome patients
@en
Granulocyte-macrophage colony- ...... odeficiency syndrome patients.
@nl
type
label
Granulocyte-macrophage colony- ...... nodeficiency syndrome patients
@ast
Granulocyte-macrophage colony- ...... nodeficiency syndrome patients
@en
Granulocyte-macrophage colony- ...... odeficiency syndrome patients.
@nl
prefLabel
Granulocyte-macrophage colony- ...... nodeficiency syndrome patients
@ast
Granulocyte-macrophage colony- ...... nodeficiency syndrome patients
@en
Granulocyte-macrophage colony- ...... odeficiency syndrome patients.
@nl
P2093
P2860
P356
P1476
Granulocyte-macrophage colony- ...... nodeficiency syndrome patients
@en
P2093
G C Baldwin
J C Gasson
J Fleischmann
R T Mitsuyasu
R Weisbart
P2860
P304
P356
10.1073/PNAS.85.8.2763
P407
P577
1988-04-01T00:00:00Z